Thursday, 6 April 2017

BGR-34 PRODUCT

Constituent Laboratories of CSIR, namely CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) and CSIR-National Botanical Research Institute (CSIR-NBRI) have jointly developed a herbal formulation named NBRMAP-DB effective against diabetes. The formulation was licensed to M/s. AIMIL Pharmaceutical Pvt. Ltd., New Delhi for manufacturing the drug and marketing the same with the brand name of BGR-34. 

The formulation was evaluated on small animal model and found effective against chemical induced type-II Diabetes mellitus. M/s. AIMIL Pharmaceutical Pvt. Ltd., New Delhi had conducted the clinical trial at Agarwal Dharmarth Hospital, New Delhi and started marketing the drug with the brand name of BGR-34. Further, more detailed studies on human subjects are being conducted at Banaras Hindu University (BHU), Varanasi. 

This information was given by Minister of State for Science & Technology and Earth Sciences Shri Y.S.Chowdary in written reply to a question in Lok Sabha.



Courtesy: pib.nic.in

No comments:

Cabinet approves continuation of the scheme on Indian Institute of Corporate Affairs beyond the 12th Plan Period

The Union Cabinet chaired by the Prime Minister Shri Narendra Modi has given its approval for continuation of the scheme on Indian Ins...